Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Steroid hormones and carcinogenesis of the prostate: the role of estrogens.

Ricke WA, Wang Y, Cunha GR.

Differentiation. 2007 Nov;75(9):871-82. Epub 2007 Oct 9. Review.

PMID:
17924963
2.
3.

The dual, opposing roles of estrogen in the prostate.

Ellem SJ, Risbridger GP.

Ann N Y Acad Sci. 2009 Feb;1155:174-86. doi: 10.1111/j.1749-6632.2009.04360.x. Review.

PMID:
19250203
4.

Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.

Carruba G.

J Cell Biochem. 2007 Nov 1;102(4):899-911. Review.

PMID:
17786930
5.

Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.

Ho SM, Leung YK, Chung I.

Ann N Y Acad Sci. 2006 Nov;1089:177-93. Review.

PMID:
17261766
6.

Role of estrogens in development of prostate cancer.

Härkönen PL, Mäkelä SI.

J Steroid Biochem Mol Biol. 2004 Nov;92(4):297-305. Epub 2004 Dec 19. Review.

PMID:
15663993
7.

Selective estrogen receptor modulators for the chemoprevention of prostate cancer.

Steiner MS, Raghow S, Neubauer BL.

Urology. 2001 Apr;57(4 Suppl 1):68-72.

PMID:
11295598
8.

The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.

Platz EA, Giovannucci E.

J Steroid Biochem Mol Biol. 2004 Nov;92(4):237-53. Epub 2005 Jan 5. Review.

PMID:
15663987
9.

Developmental estrogenization and prostatic neoplasia.

Santti R, Newbold RR, Mäkelä S, Pylkkänen L, McLachlan JA.

Prostate. 1994;24(2):67-78. Review.

PMID:
7508622
10.

The role of steroid hormones in prostate carcinogenesis.

Bosland MC.

J Natl Cancer Inst Monogr. 2000;(27):39-66. Review.

PMID:
10963619
11.

Aromatase and prostate cancer.

Ellem SJ, Risbridger GP.

Minerva Endocrinol. 2006 Mar;31(1):1-12. Review.

PMID:
16498360
12.

Estrogenic effects on prostatic differentiation and carcinogenesis.

Cunha GR, Wang YZ, Hayward SW, Risbridger GP.

Reprod Fertil Dev. 2001;13(4):285-96. Review.

PMID:
11800167
13.

Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate.

Adams JY, Leav I, Lau KM, Ho SM, Pflueger SM.

Prostate. 2002 Jun 1;52(1):69-81.

PMID:
11992621
14.

Preprostatectomy: A clinical model to study stromal-epithelial interactions.

Lopaczynski W, Hruszkewycz AM, Lieberman R.

Urology. 2001 Apr;57(4 Suppl 1):194-9.

PMID:
11295626
15.

A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver.

Singh PB, Matanhelia SS, Martin FL.

Eur J Cancer. 2008 May;44(7):928-36. doi: 10.1016/j.ejca.2008.02.051. Epub 2008 Apr 1. Review.

PMID:
18381236
16.

Role of stroma in carcinogenesis of the prostate.

Cunha GR, Hayward SW, Wang YZ.

Differentiation. 2002 Dec;70(9-10):473-85. Review.

PMID:
12492490
17.

The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089.

Perez-Stable CM, Schwartz GG, Farinas A, Finegold M, Binderup L, Howard GA, Roos BA.

Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):555-63.

18.

Estrogens and mechanisms of prostate cancer progression.

Carruba G.

Ann N Y Acad Sci. 2006 Nov;1089:201-17. Review.

PMID:
17261768
19.
20.

Effect of pubertal development on estrogen receptor levels and stromal morphology in the guinea pig prostate.

Tilley WD, Horsfall DJ, Skinner JM, Henderson DW, Marshall VR.

Prostate. 1989;15(2):195-210.

PMID:
2678040

Supplemental Content

Support Center